CZECRIN

IHBT is a part of the network of cooperating clinical units in the national scientific network CZECRIN.

CZECRIN is a key infrastructure supporting the implementation of academic clinical research in the Czech Republic. As the Czech node of the European Network of Clinical Research Infrastructures, ECRIN-ERIC contributes in a fundamental way to the involvement of academic institutions in international clinical research projects. It has a unique network including the majority of important clinical workplaces which focus on clinical research and provides knowledge, development, production, and implementation capacities in the field of research and development of medicines and medical devices. It sets the quality of processes and data with regard to the application of FAIR principles. CZECRIN is also a center for cultivation and education in the field of clinical studies.

IHBT has been part of the network of cooperating clinical units since 2020.

Cyril Šálek, MD M.Sc. Ph.D. is one of the members of the CZECRIN Board.

The Department of Academic Clinical Studies is a cooperating unit (within the Clinical Trial Unit structure), see https://czecrin.cz/o-nas/organizacni-struktura/.

At the same time Cyril Šálek, MD. M.Sc. Ph.D. initiates the establishment of the sector-oriented CZECRIN HEMATO network, see https://czecrin.cz/expertiza-a-sluzby/donet/.